Carlisle Companies Incorporated Revenue Growth Rates (CSL), Current and Historic Growth - CSIMarket
CSIMarket
 


Carlisle Companies Incorporated  (NYSE: CSL)
 

CSL's Revenue Growth by Quarter and Year

Carlisle Companies Incorporated's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CSL/growth
https://api.csimarket.com/api/v1/companies/CSL/fundamentals
https://api.csimarket.com/api/v1/companies/CSL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CSL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1,463.40
2nd Quarter June 1,570.30
1st Quarter March 1,052.10
FY 4,085.80

CSLs Annual Revenue
Carlisle Companies Incorporated's Revenue in the fiscal year 2025 $ 5,019.90 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2024 $ 5,003.60 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2023 $ 4,586.90 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2022 $ 6,591.90 millions
Carlisle Companies Incorporated's Revenue in the fiscal year 2021 $ 4,810.30 millions




CSL Revenue third quarter 2026 Y/Y Growth Comment
Carlisle Companies Incorporated achieved in the third quarter 2026, above Company average Revenue improvement of 8.65% year on year, to $ 1,463.40 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 138 other companies have achieved higher Revenue growth. While Carlisle Companies Incorporated' s Revenue increase of 8.65% ranks overall at the positon no. 2626 in the third quarter 2026.




CSL Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 8.65 %
2nd Quarter June 8.33 %
1st Quarter March -3.99 %
FY   -

Financial Statements
Carlisle Companies Incorporated's third quarter 2026 Revenue $ 1,463.40 millions CSL's Income Statement
Carlisle Companies Incorporated's third quarter 2025 Revenue $ 1,346.90 millions Quarterly CSL's Income Statement


CSL Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -6.81 %
2nd Quarter June 49.25 %
1st Quarter March -6.7 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #379
Overall #2626

Revenue Y/Y Growth Statistics
High Average Low
40.09 % 5.38 % -22.75 %
(Sep 30 2022)   (Dec 31 2023)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #139
Healthcare Sector #379
Overall #2626
Revenue Y/Y Growth Statistics
High Average Low
40.09 % 5.38 % -22.75 %
(Sep 30 2022)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Carlisle Companies Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
49.25 % 3.04 % -38.64 %
(Jun 30 2026)  


CSL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Carlisle Companies Incorporated disclosed decline in Revenue from the second quarter by -6.81% to $ 1,463.40 millions, from $ 1,570.30 millions achived in the previous reporting period.

But that's not important problem, as Carlisle Companies Incorporated's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Carlisle Companies Incorporated's Revenue growth quarter on quarter, overall rank is 244.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #66
Overall #244
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #66
Overall #244
Revenue Q/Q Growth Statistics
High Average Low
49.25 % 3.04 % -38.64 %
(Jun 30 2026)  


CSL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Carlisle Companies Incorporated disclosed decline in Revenue from the second quarter by -6.81% to $ 1,463.40 millions, from $ 1,570.30 millions achived in the previous reporting period.

But that's not important problem, as Carlisle Companies Incorporated's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Carlisle Companies Incorporated's Revenue growth quarter on quarter, overall rank is 244.


Carlisle Companies Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 5,213.50
Y / Y Revenue Growth (TTM) 3.96 %
Year on Year Revenue Growth Overall Ranking # 2499
Seqeuential Revenue Change (TTM) 2.29 %
Seq. Revenue Growth (TTM) Overall Ranking # 2636


Cumulative Revenue growth Comment
Although Carlisle Companies Incorporated's Annual Revenue growth year on year were below company's average 5.22% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.96% year on year, from 1.9% in Jun 30 2026.

In the Healthcare sector 357 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2446 to 2499.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 358
Overall # 2499

Revenue TTM Y/Y Growth Statistics
High Average Low
27.91 %
5.22 %
-20.28 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 379
S&P 500 # 2636
Cumulative Revenue growth Comment
Although Carlisle Companies Incorporated's Annual Revenue growth year on year were below company's average 5.22% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.96% year on year, from 1.9% in Jun 30 2026.

In the Healthcare sector 357 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2446 to 2499.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 358
Overall # 2499

Revenue TTM Y/Y Growth Statistics
High Average Low
27.91 %
5.22 %
-20.28 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 379
S&P 500 # 2636




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CSL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions
Tandem Diabetes Care Inc 14.26%$ 14.257 millions
Iradimed Corporation14.15%$ 14.154 millions
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions
Indivior Pharmaceuticals Inc 13.74%$ 13.738 millions
Cryoport inc 13.54%$ 13.535 millions
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions
Privia Health Group Inc 13.19%$ 13.187 millions
Biocryst Pharmaceuticals Inc 13.11%$ 13.110 millions
U S Physical Therapy Inc12.90%$ 12.898 millions
Maravai Lifesciences Holdings Inc 12.78%$ 12.781 millions
Alphatec Holdings Inc 12.67%$ 12.670 millions
Harmony Biosciences Holdings inc 12.61%$ 12.609 millions
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions


About Carlisle Companies Incorporated Revenue Growth Rates (CSL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Carlisle Companies Inc (CIK 790051).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000790051-26-000053
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Carlisle Companies Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.